The size of the generic drug market in the US is so large that about 90% of all prescription medicines sold last
Pfizer Inc.
-(PFE)
XNYS:PFE
Pharma stocks: Merck is on a buying spree
Several merger and acquisition deals are being announced in the healthcare sector, the most recent one being the acquisition of Array Biopharma
Pfizer boosts oncology portfolio with $10-Bil acquisition of Array Biopharma
In a sign that the consolidation wave that swept in the pharmaceutical industry last year is likely to continue, Pfizer (NYSE: PFE)
What’s in store for top pharma stocks this year
The stocks of leading pharmaceutical firms shifted to growth mode this year after winding up 2018 on a low note, in line
Intercept Pharmaceuticals reports mixed Q1 results
Intercept Pharmaceuticals (NASDAQ: ICPT) reported wider-than-expected losses in the first quarter of 2019, primarily due to higher R&D expenses related to NASH
Pfizer Q1 profit tops expectations; raises FY19 earnings outlook
Pharma giant Pfizer (NYSE: PFE) Tuesday reported stronger than expected earnings and revenues for the first quarter of 2019. The company also
Calendar: Earnings of Alphabet, Pfizer, Merck, Apple, Gilead on queue
Alphabet, Pfizer, Merck, Apple, Gilead Sciences, and more earnings are scheduled for the week between April 29 and May 3. Check out
Axsome Therapeutics stock climbs to 34-month high
After the slump on weak quarterly results, investors turned positive on Axsome Therapeutics (AXSM) stock, which climbed to the 34-month high of
Earnings preview: Amarin likely to deliver strong Q4 results
Amarin Corporation (AMRN) is scheduled to report earnings results for the fourth quarter of 2018 on Wednesday, February 27, before the market
Amarin shares jump 14% on rumors over Novartis interest
Shares of Amarin Corp (AMRN) gained up to 14% during the regular trading hours on Friday as rumors of an acquisition once
Earnings: Array BioPharma delivers strong Q2 results, investors cheer
Array BioPharma (ARRY) reported 44% jump in second-quarter revenue to $82.5 million, driven by higher product sales and recognition of $40 million
Alexion Pharma stock jumps after Q4 results top expectations
Benefitting from the continued sales growth across all markets, led by cancer drug Soliris, Alexion Pharma (ALXN) Monday reported a double-digit increase
Earnings: Pfizer edges past Q4 estimates, shares dip on weak outlook
Pfizer (PFE) reported a better-than-expected 2% increase in fourth-quarter revenues to $13.9 billion. Earnings rose to 64 cents per share from 62
Earnings preview: Botox to drive Allergan’s growth in Q4
Allergan plc (AGN) is set to report its fourth-quarter 2018 earnings results on Tuesday, January 29, before market open. Analysts expect earnings
Amgen set to report Q4 earnings on Jan. 29. What’s in store?
Amgen (AMGN) will be reporting its fourth quarter and full-year 2018 earnings results on Tuesday, January 29 after market closes. Analysts expect
Earnings Preview: All eyes on the Pfizer-Glaxo JV
Pfizer Inc. (PFE) is scheduled to report earnings results for the fourth quarter of 2018 on Tuesday, January 29, before market open.
Companies reporting earnings in the week: Jan 28 – Feb 1
A slew of major companies are reporting earnings in the week from January 28 till February 1. Telecom giant Verizon Communications Inc.
GSK teams up with Pfizer to announce major changes to business
GlaxoSmithKline plc (GSK) and Pfizer Inc. (PFE) have decided to combine their consumer health businesses in an all-equity transaction that is expected
Pfizer pares recent gains after JP Morgan slashes rating
The outlook for Pfizer (PFE) remains mixed as the drug maker gears up for a closely-followed leadership change early next year. While
Allergan, Mylan and other generics beam as Pfizer loses patent war in the UK
It was good news for generic drug firms such as Allergan (AGN) and Mylan (MYL), as pharma giant Pfizer (PFE) lost a